AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06561646 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: single-port robotic-assisted nipple-sparing mastectomy and axillary lymph node dissection
Description: the single-port robotic-assisted nipple-sparing mastectomy and axillary lymph node dissection in the management of breast cancer
Study NCT04300946 — intervention group
Intervention type: DEVICE
Intervention: TMS targeted on the cerebellum
Description: Impact on EEG performance (preparation wave in temporal tasks) of cerebellar stimulation by MSD in healthy subjects. The contrast between the post-stimulation effects of verrum stimulation and placebo stimulation will indicate the magnitude of the effect and will allow us to optimize the type of protocol that may be useful in schizophrenia.
Study NCT04820309 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xanomeline and Trospium Chloride Capsules
Description: Oral xanomeline 50 mg/trospium 20 mg BID on days 1-2 followed by xanomeline 100 mg/trospium 20 mg BID on days 3-7. The dose is increased to xanomeline 125 mg/trospium 30 mg BID on days 8-364 unless the subject is experiencing adverse events from the xanomeline 100 mg/ trospium 20 mg dose. Subjects who were increased to xanomeline 125 mg/trospium 30 mg will have the option to return to xanomeline 100 mg/ trospium 20 mg depending on clinical response and tolerability. Re-escalation to 125/30 BID or re-titration in cases in which the subject has been off KarXT for a longer period of time (at least a week) is allowed and will require a discussion between the principal investigator and the medical monitor.
Study NCT04648371 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Remediation and Transcranial Direct Current Stimulation
Description: Cognitive Remediation (CR) is a well-established psychosocial group intervention that aims to improve neurocognitive abilities such as memory performance, executive functioning, processing speed, and attention.~Transcranial Direct Current Stimulation (tDCS) is a non-invasive brain stimulation method that can be safely administered to awake outpatients. It does not require general anesthesia or surgical implantation. It utilizes low intensity electrical current (e.g., 2 mA) either to increase cortical excitability with an anodal electrode or to suppress cortical excitability with a cathodal electrode.
Study NCT04648371 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Cognitive Remediation and Transcranial Direct Current Stimulation
Description: Cognitive Remediation (CR) is a well-established psychosocial group intervention that aims to improve neurocognitive abilities such as memory performance, executive functioning, processing speed, and attention.~Transcranial Direct Current Stimulation (tDCS) is a non-invasive brain stimulation method that can be safely administered to awake outpatients. It does not require general anesthesia or surgical implantation. It utilizes low intensity electrical current (e.g., 2 mA) either to increase cortical excitability with an anodal electrode or to suppress cortical excitability with a cathodal electrode.
Study NCT05235581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention A : virtual environment with avatar
Description: 30-second right and left unipodal static and dynamic balance test with avatar only
Study NCT05235581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention B : virtual environment with reinforced visual signal
Description: 30-second right and left unipodal static and dynamic balance test with reinforced visual signal only
Study NCT05235581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention C : virtual environment with avatar and reinforced visual signal
Description: 30-second right and left unipodal static and dynamic balance test with avatar and reinforced visual signal
Study NCT05235581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention D : real environment
Description: 30-second right and left unipodal static and dynamic balance test in real environment
Study NCT04757298 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Navigation Services
Description: Navigation services include assessment and support with service referrals. Each participant will meet with a peer navigator in person or on Zoom Conferencing for 30 minutes to go over results from their social and health needs assessment that is retrieved from the baseline assessment. The navigator shares information about COVID-19, answers questions about testing, and makes referrals to other needed services
Study NCT04757298 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Critical Dialogue
Description: Critical Dialogue includes three one-hour-long, open-group-sessions facilitated in person or online by a trained licensed facilitator. Group critical dialogue is prompted by thematic images developed by the NCCB to foster a deeper understanding of how systematic stigma, feelings of rage as victims of discrimination, and/or apathy may impact participants' beliefs and behaviors related to COVID-19 and empower participants to make critical choices to protect their health and the health of their communities.
Study NCT04757298 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Brief Counseling
Description: Brief Counseling is a 15-minute post-COVID-19 test session delivered by a trained licensed clinician in person or via Zoom Conferencing. In the session, the clinician shares the test results and offers recommendations and information about COVID-19 treatment and prevention.
Study NCT04757298 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Referral and Digital Brochure
Description: Referral will consist of a five-minute phone call where an outreach worker offers participants information about COVID-19 testing and encourages them to get tested within one week. A digital brochure containing NJ recommendations is e-mailed or texted to participants.
Study NCT05215483 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Customised testing advice
Description: Customised advice: With Corona related symptoms, get tested at a test facility. If this isn't possible, use a Lateral Flow test.
Study NCT05215483 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regular testing advice
Description: Government guideline testing advice: With Corona related symptoms, get tested at a test facility.
Study NCT05215483 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Regular testing advice
Description: Government guideline testing advice: With Corona related symptoms, get tested at a test facility.
Study NCT05215483 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LFT available
Description: LFT availability: Enough lateral flow tests available at home
Study NCT05215483 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No LFT available
Description: LFT availability: No lateral flow tests available at home
Study NCT05215483 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No LFT available
Description: LFT availability: No lateral flow tests available at home
Study NCT05400694 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food
Description: Dairy products with reduced sugar content
Study NCT06196099 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Blood Flow Restriction
Description: The study participants were instructed to rest quietly in a seated position for 10 minutes. During the last 3 minutes of the resting period, upper arm blood pressure was measured twice using an automatic blood pressure monitor (BP170, InBody, Korea). The blood flow restriction cuffs (BFR Therapy Cuff, BFR Therapy Co., USA) - measuring 5cm in width and 60cm in length - were applied to the upper third of the thigh on both legs. To maintain consistency in measurements, the distance from the proximal part of the kneecap to the distal edge of the cuff was measured. A Capillary Reaction Time (CRT) test was used to assess the appropriateness of the cuff pressure; this involved applying thumb pressure to the quadriceps muscle after cuff application and timing how long it took for the skin color to return to normal.
Study NCT06196099 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Neuromuscular Electrical Stimulation
Description: Neuromuscular Electrical Stimulation (NMES) was applied five times a week for one week using a four-channel stimulator (Compex Physio, Chattanooga, Switzerland). The stimulation protocol was set to a frequency of 35Hz, with electrodes attached to the vastus lateralis and vastus medialis muscles. The therapist adjusted the intensity and alternating output of the electrodes selectively to facilitate the squat exercises required during the intervention. During the stimulation period, participants were engaged in a squat exercise program, with the total duration of stimulation being 10 minutes.
Study NCT06196099 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Squat exercise
Description: In this study, the squat exercise was performed in four sets. Participants were instructed to position their feet shoulder-width apart and educated to squat in such a way that their knees did not extend beyond their toes. To ensure consistency in performing the squat at the same angle, a mark was made on the wall at the pelvic height during a 90° squat. This allowed participants to perform squats at the same height. The exercise was conducted under the guidance of a physical therapist with five years of clinical experience.
Study NCT06165965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SGLT2 inhibitor
Description: SGLT2 dual inhibitor
Study NCT06165965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitor
Description: SGLT2 dual inhibitor
Study NCT05730673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 700mg leronlimab weekly dose
Description: leronlimab is a humanized IgG4,κ monoclonal antibody (mAb) to the chemokine receptor CCR5
Study NCT05730673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 80mg Regorafenib at week 1
Description: Regorafenib is a small-molecule multiple kinase inhibitor
Study NCT05730673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 120mg Regorafenib at week2
Description: Regorafenib is a small-molecule multiple kinase inhibitor
Study NCT05730673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 160 mg Regorafenib at week 3
Description: Regorafenib is a small-molecule multiple kinase inhibitor
Study NCT06208631 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gait retraining
Description: Changing muscle coordination while walking
Study NCT06173648 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser and ICG solution.
Description: Intervention consists of addition of a combined laser absorption solution and infrared diode laser. The solution is introduced into the prepared pulp chamber and root canals, allowed to dwell for 1 minute, followed by exposure to the laser energy delivered via a fiber optic introduced into the root canal, and while activating the laser at 2.5 watts of optical output with a pulse duration of 100 msec and a pulse gap of 300 msec, the solution and residual structures in the root and pulp chamber are exposure over the course of 30 seconds, moving and relocating the fiber tip throughout the canals and chamber during that time. The laser is halted and a wait time of 30 seconds is applied. The laser fiber is then reintroduced and another 30 second exposure, repeating the same settings and technique.
Study NCT05388305 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR--γδT cells
Description: Biological: CAR-γδT; Drug:
Study NCT06241963 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Unilateral real High definition transcranial direct current stimulation
Description: Improvement of cortical excitability, unilateral stimulation was effective, and no side effects were observed
Study NCT06241963 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Bilateral real High definition transcranial direct current stimulation
Description: Improved cortical excitability, the effect was more obvious than unilateral stimulation, the effect lasted longer, and no side effects were observed
Study NCT06241963 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator: Sham High definition transcranial direct current stimulation
Description: The sham stimulation is mainly used for blank control, control variables, and exclude the interference of other factors
Study NCT06035250 — intervention group
Intervention type: DRUG
Intervention: Neoadjuvant Chemotherapy
Description: Participants in this group are diagnosed with gastric cancer and are scheduled to undergo neoadjuvant chemotherapy as a part of their treatment regimen. The specific chemotherapy drugs, dosages, and schedules will be determined according to established clinical guidelines and the participant's specific condition.
Study NCT05527561 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Latin dance: Rumba
Description: Latin dance is a kind of sports dance, which originated in Latin America, includes the rumba, samba, Cha Cha Cha, bullfighting dances and cowboy dances. The intensity of the training is increasing in the first 20 minutes, and the intensity is gradually decreasing in the next 5 minutes.
Study NCT05527561 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Latin dance: Cha Cha Cha
Description: Latin dance is a kind of sports dance, which originated in Latin America, includes the rumba, samba, Cha Cha Cha, bullfighting dances and cowboy dances. The intensity of the training is increasing in the first 20 minutes, and the intensity is gradually decreasing in the next 5 minutes.
Study NCT05357235 — intervention group
Intervention type: DRUG
Intervention: PEG-IFN
Description: PEG-IFN 180 or 135 micrograms, subcutaneously injected once a week, with a personalized treatment course of 24 weeks
Study NCT02928094 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad5FGF-4
Description: Ad5FGF-4 administered via intracoronary infusion using standard balloon catheter, and under conditions of transient ischemia.
Study NCT02928094 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo buffer administered via intracoronary infusion using standard balloon catheter, without transient ischemia.
Study NCT05791591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: NUV001 - IR
Description: Daily supplementation with 1000 mg of NUV001 (in two administration orally) immediate release gel capsule formulation for 90 days in total
Study NCT05791591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: NUV001 - GR
Description: Daily supplementation with 1000 mg of NUV001 (in two administration orally) gastro resistant gel capsule formulation for 90 days in total
Study NCT05791591 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo containing starch Powder (1000 mg, daily in two administration orally for 90 days)
Study NCT04940923 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: T2 weighted and DTI MRI images of brachial plexus and wrist. Quantitative sensory tests include warm and cold detection and pain thresholds, paradoxical heat sensation, mechanical detection thresholds, mechanical pain sensation and thresholds, wind up ratios, vibration thresholds and pressure pain thresholds.~Clinical tests include standard neurological tests and test for heightened nerve mechanosensitivity.~Blood serum to analyse inflammatory proteins. Questionnaires include neck disability index, painDETECT, PTSD8, pain catastrophising scale, eq-5D-5L, DASS 42 and global perceived recovery
Study NCT06488118 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R848
Description: Inhaled R848 dose ranging from 0.1 to 100 μg/mL
Study NCT06488118 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Inhaled Saline control
Study NCT06040619 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapy Together
Description: 8-week caregiver-led pediatric constraint-induced movement therapy program
Study NCT06040619 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: 8 weeks of usual care received in an early intervention therapy program
Study NCT06127212 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg film-coated tablet
Description: One tablet of the test drug was given orally (swallowed with 240 mL of 20% glucose solution in water), after an overnight fast.
Study NCT06127212 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia
Description: One tablet of the reference drug was given orally (swallowed with 240 mL of 20% glucose solution in water), after an overnight fast.
Study NCT03423355 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin (Forxiga®)
Description: 10mg p.o. daily
Study NCT03423355 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Hydrochlorothiazide 25 mg
Description: 25mg p.o. daily
Study NCT03423355 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching Dapagliflozin
Description: Placebo matching Dapagliflozin p.o. daily
Study NCT06119581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3537982
Description: Administered orally.
Study NCT06119581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Administered IV.
Study NCT06119581 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pembrolizumab
Description: Administered IV.
Study NCT06119581 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered orally.
Study NCT06119581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered IV.
Study NCT06119581 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cisplatin
Description: Administered IV.
Study NCT06119581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Administered IV.
Study NCT06119581 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carboplatin
Description: Administered IV.
Study NCT05752864 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: spine manual therapy
Description: The manual treatment method applied to the sacroiliac joint used high-velocity, low amplitude (HVLA).
Study NCT05752864 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Superficial heat therapy
Description: In the physical therapy used in this study, it was applied for 20 minutes using conventionally used superficial heat therapy.
Study NCT04942639 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JOE
Description: Audiovisual support by the robot when taking maintenance treatments at home.
Study NCT06488950 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GC203 TIL(gene-edited TIL) or autologous TILs
Description: the candidates will be assigned to GC203 TIL(gene-edited TIL) group or autologous TILs group according the volume of TIL sample
Study NCT05621863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 1
Description: A meal challenge will be provided that contains 1 serving of peaches and 2 servings of strawberries as a smoothie and 2 servings of tomatoes and 1 serving of carrot as a vegetable dish.
Study NCT06271980 — intervention group
Intervention type: OTHER
Intervention: ENCORE
Description: A panel of microRNA, whose expression level is tested in macro-dissected formalin-fixed and paraffin-embedded (FFPE) samples derived from the primary tumor.
Study NCT05621863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 2
Description: A meal challenge will be provided that contains 1 serving of banana and 2 servings of peaches as a smoothie and 1 serving of tomatoes and 2 servings of green beans as a vegetable dish.
Study NCT04882163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-220
Description: CC-220
Study NCT04882163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin
Description: Polatuzumab vedotin
Study NCT05621863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 3
Description: A meal challenge will be provided that contains 2 serving of bananas and 1 serving of strawberries as a smoothie and 1 serving of green beans and 2 servings of carrots as a vegetable dish.
Study NCT05621863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 2 Typical American Diet
Description: The diet will provide sufficient calories for weight maintenance and will contain refined grains and low amounts of fruits and vegetables, representative of the typical American diet. No bananas, strawberries, peaches, green beans, carrots, or tomatoes will be provided.
Study NCT05621863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 2 Typical American Diet Plus Test Foods
Description: This diet will provide sufficient calories for weight maintenance and will contain refined grains and low amounts of fruits and vegetables, representative of the typical American diet. Bananas, strawberries, peaches, green beans, carrots, and tomatoes will be provided in amounts less than or equal to 1 serving per day each.
Study NCT05621863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 2 Dietary Guidelines for Americans Diet Plus Test Foods
Description: This diet will provide sufficient calories for weight maintenance and will contain whole grains and high amounts of fruits and vegetables, representative of the Dietary Guidelines for Americans. Bananas, strawberries, peaches, green beans, carrots, and tomatoes will be provided in amounts greater than or equal to 1 serving per day each.
Study NCT06119581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Administered IV.